JavaScript must be enabled in order for you to fully use this site. However, it seems JavaScript is either disabled or not supported by your browser. To use this site, enable JavaScript by changing your browser options, then try again.
More
Black Hills Regional Eye Institute Toll Free: Click For Map & Directions
A Phase 2, randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous injections of E10030 (anti-PDGF pegylated aptamer) given in combination with Lucentis in subjects with neovascular age-related macular degeneration.
Candidates for this study include the treatment of naïve patients with subfoveal choroidal neovascular membrane secondary to age-related macular degeneration.